Denlinger Crystal S, Carlson Robert W, Are Madhuri, Baker K Scott, Davis Elizabeth, Edge Stephen B, Friedman Debra L, Goldman Mindy, Jones Lee, King Allison, Kvale Elizabeth, Langbaum Terry S, Ligibel Jennifer A, McCabe Mary S, McVary Kevin T, Melisko Michelle, Montoya Jose G, Mooney Kathi, Morgan Mary Ann, O'Connor Tracey, Paskett Electra D, Raza Muhammad, Syrjala Karen L, Urba Susan G, Wakabayashi Mark T, Zee Phyllis, McMillian Nicole, Freedman-Cass Deborah
J Natl Compr Canc Netw. 2014 Feb;12(2):184-92. doi: 10.6004/jnccn.2014.0019.
Cancer treatment, especially hormonal therapy and therapy directed toward the pelvis, can contribute to sexual problems, as can depression and anxiety, which are common in cancer survivors. Thus, sexual dysfunction is common in survivors and can cause increased distress and have a significant negative impact on quality of life. This section of the NCCN Guidelines for Survivorship provides screening, evaluation, and treatment recommendations for female sexual problems, including those related to sexual desire, arousal, orgasm, and pain.
癌症治疗,尤其是激素疗法和针对骨盆的治疗,可能会导致性功能问题,抑郁症和焦虑症也会如此,而这在癌症幸存者中很常见。因此,性功能障碍在幸存者中很常见,会导致痛苦加剧,并对生活质量产生重大负面影响。NCCN生存指南的这一部分提供了针对女性性功能问题的筛查、评估和治疗建议,包括与性欲、性唤起、性高潮和疼痛相关的问题。